General Atlantic has made a strategic investment in Sonendo. The growth equity firm will be joining existing investors Fjord Ventures, OrbiMed Advisors, Meritech Capital Partners, CVF, and NeoMed to lead Sonendo’s latest fundraising round, which is valued at $50 million. In its next phase of growth, Sonendo plans to accelerate its ongoing commercialization efforts and further expand and diversify its current product portfolio.
“Sonendo is committed to developing technologies that are transformative and align with our mission of saving teeth through sound science,” said Bjarne Bergheim, president and CEO of Sonendo. “With its strong track record partnering with successful, high-growth companies in the healthcare sectors, General Atlantic is an ideal partner for our next phase of growth.”
“We believe there is a unique opportunity for Sonendo to transform the dental industry with its innovative technology that benefits both dentists and patients alike,” said David Caluori, principal at General Atlantic, who will be joining Sonendo’s board of directors. “We look forward to partnering with Bjarne and the entire management team to support the company’s growth and commitment to developing unique technology intended for a market of underserved consumers and dentists.”
Sonendo was founded in 2006 by Fjord Ventures. Its flagship technology, the GentleWave System, presents an alternative to standard root canal treatment and a departure from the standard file-based method of tissue removal and disinfection. Drawing from 37 years of experience investing in more than 250 global growth companies, General Atlantic partners with entrepreneurs and management teams building leading, high-growth businesses.
FDA Clears Next-Generation GentleWave System
Exclusive Interview: GentleWave Versus PIPS
GentleWave Procedure: The Next Big Revolution in Root Canal Treatment